Variation in US Commercial Health Plan Coverage Restrictions for Cell and Gene Therapies

This Viewpoint examines variations in US commercial health plan coverage restrictions for cell and gene therapies.

Authors

Peter J. Neumann (ORCID: https://orcid.org/0000-0003-1226-4073)
Daniel E. Enright
James D. Chambers (ORCID: https://orcid.org/0000-0001-5696-4894)
Julia A. Rucker
Molly T. Beinfeld

Institutions

Tufts Medical Center (US)

Publication Details

Journal: JAMA
Published: 2025-09-29
DOI: https://doi.org/10.1001/jama.2025.15148
Primary Topic: Health Systems, Economic Evaluations, Quality of Life
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Variation in US Commercial Health Plan Coverage Restrictions for Cell and Gene Therapies

Peter J. Neumann, Daniel E. Enright, James D. Chambers, Julia A. Rucker et al.

Sep 29, 2025

JAMA

Health Systems, Economic Evaluations, Quality of Life

article

Variation in US Commercial Health Plan Coverage Restrictions for Cell and Gene Therapies

Peter J. Neumann, Daniel E. Enright, James D. Chambers, Julia A. Rucker, Molly T. Beinfeld

September 29, 2025article en

Abstract

This Viewpoint examines variations in US commercial health plan coverage restrictions for cell and gene therapies.

JAMAVol. 334(18)

Tufts Medical Center (US)

Openalex Percentile: Top 65%

Health Systems, Economic Evaluations, Quality of Life

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Variation in US Commercial Health Plan Coverage Restrictions for Cell and Gene Therapies — Peter J. Neumann, Daniel E. Enright, et al. · JAMA (2025) | TGRS Research Map | TGRS